These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 35023260)

  • 1. Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19: A randomized double-blind placebo-controlled trial.
    Honarkar Shafie E; Taheri F; Alijani N; Okhovvat AR; Goudarzi R; Borumandnia N; Aghaghazvini L; Rezayat SM; Jamalimoghadamsiahkali S; Hosseinzadeh-Attar MJ
    Phytother Res; 2022 Feb; 36(2):1013-1022. PubMed ID: 35023260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Nanocurcumin as an Add-On Treatment for Patients Hospitalized with COVID-19: A Double-Blind, Randomized Clinical Trial.
    Ahmadi S; Mehrabi Z; Zare M; Ghadir S; Masoumi SJ
    Int J Clin Pract; 2023; 2023():5734675. PubMed ID: 37547100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanocurcumin supplementation ameliorates Behcet's disease by modulating regulatory T cells: A randomized, double-blind, placebo-controlled trial.
    Abbasian S; Soltani-Zangbar MS; Khabbazi A; Farzaneh R; Malek Mahdavi A; Motavalli R; Hajialilo M; Yousefi M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108237. PubMed ID: 34653732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nanocurcumin supplementation on T-helper 17 cells inflammatory response in patients with Behcet's disease: a randomized controlled trial.
    Farzaneh R; Khabbazi A; Soltani-Zangbar MS; Abbasian S; Malek Mahdavi A; Motavalli R; Yousefi M
    Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):206-215. PubMed ID: 35021944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial.
    Askari G; Bagherniya M; Kiani Z; Alikiaii B; Mirjalili M; Shojaei M; Hassanizadeh S; Vajdi M; Feizi A; Majeed M; Sahebkar A
    Adv Exp Med Biol; 2023; 1412():413-426. PubMed ID: 37378780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trial.
    Varnasseri M; Siahpoosh A; Hoseinynejad K; Amini F; Karamian M; Yad MJY; Cheraghian B; Khosravi AD
    Complement Ther Med; 2022 May; 65():102808. PubMed ID: 35093510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, Double-blind Pilot Study of Nanocurcumin in Bladder Cancer Patients Receiving Induction Chemotherapy.
    Sandoughdaran S; Razzaghdoust A; Tabibi A; Basiri A; Simforoosh N; Mofid B
    Urol J; 2021 Apr; 18(3):295-300. PubMed ID: 32350847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
    Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
    Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.
    Aman J; Duijvelaar E; Botros L; Kianzad A; Schippers JR; Smeele PJ; Azhang S; Bartelink IH; Bayoumy AA; Bet PM; Boersma W; Bonta PI; Boomars KAT; Bos LDJ; van Bragt JJMH; Braunstahl GJ; Celant LR; Eger KAB; Geelhoed JJM; van Glabbeek YLE; Grotjohan HP; Hagens LA; Happe CM; Hazes BD; Heunks LMA; van den Heuvel M; Hoefsloot W; Hoek RJA; Hoekstra R; Hofstee HMA; Juffermans NP; Kemper EM; Kos R; Kunst PWA; Lammers A; van der Lee I; van der Lee EL; Maitland-van der Zee AH; Mau Asam PFM; Mieras A; Muller M; Neefjes ECW; Nossent EJ; Oswald LMA; Overbeek MJ; Pamplona CC; Paternotte N; Pronk N; de Raaf MA; van Raaij BFM; Reijrink M; Schultz MJ; Serpa Neto A; Slob EMA; Smeenk FWJM; Smit MR; Smits AJ; Stalenhoef JE; Tuinman PR; Vanhove ALEM; Wessels JN; van Wezenbeek JCC; Vonk Noordegraaf A; de Man FS; Bogaard HJ
    Lancet Respir Med; 2021 Sep; 9(9):957-968. PubMed ID: 34147142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment With 25-Hydroxyvitamin D
    Maghbooli Z; Sahraian MA; Jamalimoghadamsiahkali S; Asadi A; Zarei A; Zendehdel A; Varzandi T; Mohammadnabi S; Alijani N; Karimi M; Shirvani A; Holick MF
    Endocr Pract; 2021 Dec; 27(12):1242-1251. PubMed ID: 34653608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients.
    Hassaniazad M; Eftekhar E; Inchehsablagh BR; Kamali H; Tousi A; Jaafari MR; Rafat M; Fathalipour M; Nikoofal-Sahlabadi S; Gouklani H; Alizade H; Nikpoor AR
    Phytother Res; 2021 Nov; 35(11):6417-6427. PubMed ID: 34541720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Therapy with 1% Nanocurcumin Gel and 0.1% Triamcinolone Acetonide Mouth Rinse for Oral Lichen Planus: A Randomized Double-Blind Placebo Controlled Clinical Trial.
    Bakhshi M; Gholami S; Mahboubi A; Jaafari MR; Namdari M
    Dermatol Res Pract; 2020; 2020():4298193. PubMed ID: 32518558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Nanocurcumin in Improvement of Knee Osteoarthritis: A Randomized Clinical Trial.
    Hashemzadeh K; Davoudian N; Jaafari MR; Mirfeizi Z
    Curr Rheumatol Rev; 2020; 16(2):158-164. PubMed ID: 31868149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of nanocurcumin supplementation on inflammation in hemodialysis patients: A randomized controlled trial.
    Vafadar-Afshar G; Rasmi Y; Yaghmaei P; Khadem-Ansari MH; Makhdoomi K; Rasouli J
    Hemodial Int; 2021 Apr; 25(2):232-239. PubMed ID: 33559343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease.
    Gommans DHF; Nas J; Pinto-Sietsma SJ; Koop Y; Konst RE; Mensink F; Aarts GWA; Konijnenberg LSF; Cortenbach K; Verhaert DVM; Thannhauser J; Mol JQ; Rooijakkers MJP; Vos JL; van Rumund A; Vart P; Hassing RJ; Cornel JH; de Jager CPC; van den Heuvel MM; van der Hoeven HG; Verbon A; Pinto YM; van Royen N; van Kimmenade RRJ; ; de Leeuw PW; van Agtmael MA; Bresser P; ; van Gilst WH; Vonk-Noordergraaf A; Tijssen JGP; ; van Royen N; de Jager CPC; van den Heuvel MM; van der Hoeven HG; Verbon A; Pinto YM; van Kimmenade RRJ
    Am Heart J; 2020 Aug; 226():60-68. PubMed ID: 32512291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy.
    Saadipoor A; Razzaghdoust A; Simforoosh N; Mahdavi A; Bakhshandeh M; Moghadam M; Abdollahi H; Mofid B
    Phytother Res; 2019 Feb; 33(2):370-378. PubMed ID: 30427093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial.
    Akbari N; Ostadrahimi A; Tutunchi H; Pourmoradian S; Farrin N; Najafipour F; Soleimanzadeh H; Kafil B; Mobasseri M
    J Trace Elem Med Biol; 2022 May; 71():126945. PubMed ID: 35183882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial.
    Doaei S; Gholami S; Rastgoo S; Gholamalizadeh M; Bourbour F; Bagheri SE; Samipoor F; Akbari ME; Shadnoush M; Ghorat F; Mosavi Jarrahi SA; Ashouri Mirsadeghi N; Hajipour A; Joola P; Moslem A; Goodarzi MO
    J Transl Med; 2021 Mar; 19(1):128. PubMed ID: 33781275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: A randomized, double-blind, placebo-controlled clinical trial.
    Ahmadi M; Hajialilo M; Dolati S; Eghbal-Fard S; Heydarlou H; Ghaebi M; Ghassembaglou A; Aghebati-Maleki L; Samadi Kafil H; Kamrani A; Rahnama B; Rikhtegar R; Yousefi M
    J Cell Biochem; 2020 Jan; 121(1):103-110. PubMed ID: 31074089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial.
    Jeronimo CMP; Farias MEL; Val FFA; Sampaio VS; Alexandre MAA; Melo GC; Safe IP; Borba MGS; Netto RLA; Maciel ABS; Neto JRS; Oliveira LB; Figueiredo EFG; Oliveira Dinelly KM; de Almeida Rodrigues MG; Brito M; Mourão MPG; Pivoto João GA; Hajjar LA; Bassat Q; Romero GAS; Naveca FG; Vasconcelos HL; de Araújo Tavares M; Brito-Sousa JD; Costa FTM; Nogueira ML; Baía-da-Silva DC; Xavier MS; Monteiro WM; Lacerda MVG;
    Clin Infect Dis; 2021 May; 72(9):e373-e381. PubMed ID: 32785710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.